Private Advisor Group, LLC Alaunos Therapeutics, Inc. Transaction History

Private Advisor Group, LLC

$15.6 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$0.04 - $0.13 $1,126 - $3,661	-28,162 Reduced 29.37%	67,735 $4,000
Q3 2023 Nov 02, 2023	SELL	$0.12 - $0.5 $1,489 - $6,207	-12,415 Reduced 11.46%	95,897 $12,000
Q2 2023 Aug 09, 2023	SELL	$0.43 - $0.65 $1,402 - $2,120	-3,262 Reduced 2.92%	108,312 $55,000
Q1 2023 May 10, 2023	SELL	$0.46 - $0.81 $460 - $810	-1,000 Reduced 0.89%	111,574 $70,000
Q4 2022 Jan 18, 2023	SELL	$0.5 - $261.0 $3,400 - $1.77 Million	-6,800 Reduced 5.7%	112,574 $0
Q3 2022 Oct 14, 2022	SELL	$1.04 - $322.5 $13,266 - $4.11 Million	-12,756 Reduced 9.65%	119,374 $206,000
Q2 2022 Jul 13, 2022	SELL	$0.41 - $1.24 $45,109 - $136,429	-110,024 Reduced 45.44%	132,130 $163,000
Q1 2022 May 12, 2022	BUY	$0.62 - $1.17 $5,363 - $10,120	8,650 Added 3.7%	242,154 $158,000
Q4 2021 Feb 10, 2022	SELL	$1.09 - $1.89 $123,892 - $214,823	-113,663 Reduced 32.74%	233,504 $254,000
Q3 2021 Oct 14, 2021	BUY	$1.44 - $2.73 $177,469 - $336,453	123,243 Added 55.04%	347,167 $631,000
Q2 2021 Aug 12, 2021	SELL	$2.63 - $3.67 $141,191 - $197,023	-53,685 Reduced 19.34%	223,924 $591,000
Q1 2021 Apr 22, 2021	BUY	$2.82 - $5.6 $37,773 - $75,012	13,395 Added 5.07%	277,609 $1 Million
Q4 2020 Apr 01, 2021	BUY	$2.09 - $3.09 $129,105 - $190,878	61,773 Added 30.51%	264,214 $665,000
Q3 2020 Nov 02, 2020	BUY	$2.39 - $3.43 $16,730 - $24,010	7,000 Added 3.58%	202,441 $576,000
Q2 2020 Aug 17, 2020	SELL	$2.2 - $3.71 $10,340 - $17,437	-4,700 Reduced 2.35%	195,441 $641,000
Q1 2020 May 12, 2020	BUY	$1.9 - $4.98 $824 - $2,161	434 Added 0.22%	200,141 $490,000
Q4 2019 Feb 10, 2020	BUY	$3.95 - $5.35 $5,332 - $7,222	1,350 Added 0.68%	199,707 $942,000
Q3 2019 Nov 13, 2019	BUY	$4.13 - $6.94 $426,509 - $716,700	103,271 Added 108.61%	198,357 $865,000
Q2 2019 Aug 14, 2019	BUY	$3.98 - $6.2 $91,118 - $141,942	22,894 Added 31.71%	95,086 $554,000
Q1 2019 May 13, 2019	SELL	$2.0 - $4.4 $137,880 - $303,336	-68,940 Reduced 48.85%	72,192 $278,000
Q4 2018 Feb 11, 2019	BUY	$1.61 - $3.62 $40,195 - $90,376	24,966 Added 21.49%	141,132 $264,000
Q3 2018 Nov 01, 2018	BUY	$2.26 - $3.27 $262,535 - $379,862	116,166 New	116,166 $372,000
Q2 2018 Aug 09, 2018	SELL	$3.02 - $4.94 $270,108 - $441,833	-89,440 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$3.46 - $5.14 $309,462 - $459,721	89,440 New	89,440 $351,000
Q4 2017 Feb 07, 2018	SELL	$4.0 - $6.54 $194,268 - $317,628	-48,567 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$4.99 - $6.57 $13,063 - $17,200	2,618 Added 5.7%	48,567 $292,000
Q2 2017 Aug 10, 2017	BUY	N/A	45,949	45,949 $271,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Account